Investor Login


  • target-tape

  • TargetTape is clinically testing functional prototypes based upon their new patent-pending product embodiment in US and Canadian surgeries and is commercializing the device. This is E-Fund’s first investment, completed in late 2011. E-Fund I

  • semios-logo-300x135

  • Semios develops a range of proprietary chemical compositions to precision pheromone release and monitoring systems. E-Fund participated in its seed funding round in late 2011 and in a subsequent growth rounds in 2013 and 2014. E-Fund I and II

  • imstar

  • ImStar Therapeutics is working on a new approach to treat patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. E-Fund participated in Imstar’s seed round in 2012 as well in its early 2014 follow-on financing. E-Fund I and II

  • Redlen-logo

  • Redlen Technologies manufactures Cadmium Zinc Telluride based semiconductor materials that have unique radiation detection properties. E-Fund participated with Pangaea Ventures in Redlen’s 2014 $5.4 million Preferred A financing round in January 2014. E-Fund I and II

  • Logo-Optigo-300x238

  • Optigo Networks specializes in innovative connectivity solutions for smart buildings and security around those systems. E-fund invested in May 2014. E-Fund I and II

  • Mazza Innovation has commercialized the world’s first phytochemical extraction technology, producing high value extracts from plants, using sustainable, high performance and cost effective science. E-Fund invested in Mazza in early 2014. E-Fund I and II Mazza Innovation in the News

  • viewsIQ-logo-300x97

  • Views IQ is a medical imaging company focusing on biological microscopic applications of pathology slides. This challenging arena is the last frontier in medical digitizing technologies. E-Fund invested in March, 2015. E-Fund I and II

  • Wearable Therapeutics is best known in North America by the name of its signature product, “SnugVest” (@Snugvest).  SnugVest calms people suffering from   autism and other problems by simulating a hug. E-Fund invested in April 2015. E-Fund I and II

  • Microdermics is a Vancouver-based company focused on commercializing a novel hollow microneedle delivery platform targeting the multi-billion biopharmaceutical market, disrupting the traditional use of hypodermic-based drug injections. E-Fund invested in February 2017. E-Fund II and III

  • Proxi Logo E-Fund Portfolio

  • Proxxi has developed an industrial wearable that keeps watch over people working near medium and high voltage. It is designed to prevent injury or death by alerting the wearer before they enter the ‘limits of approach’ of a high voltage electrical field. E-Fund invested in March 2017. E-Fund II and III

  • CuePath Logo E-Fund Portfolio

  • CuePath Improper medication intake accounts for 25% of seniors hospital admissions and significantly affects their families’ emotional well-being. CuePath solves this problem with remote medication monitoring connected with popular blister packs. E-Fund invested in August 2017. E-Fund II and III

  • Navigate Surgical develops innovative motion tracking and 3D visualization technology for the dental market. E-Fund invested in December 2017. E-Fund II and III

  • Starling Minds is an online mental health platform for educational organizations that uses ML and AI to improve employees’ productivity while saving costs. E-Fund invested in February 2018. E-Fund II and III


  • BitLit Media was acquired by Rakuten Kobo Inc. in April 2017. BitLit launched an app called ‘Shelfie’ that allows people to get e-book versions of physical books in their library via patented technology and alliances with most major North American publishers  E-Fund I and II

  • bluebat_logo-300x197

  • BlueBat Games was acquired in February 2015 by Greentube of London, UK., a leading developer and provider for internet, mobile, PC and iTV and their parent company, the Novomatic Group. BlueBat games developed a social gamification engine used by casinos and social gambling game developers and related software. E-Fund I 

  • soloegear1

  • Solegear Bioplastics went public in January 2015 and was renamed Good Natured Products Inc. in 2017. Solegear designs, develops, manufactures and distributes non-toxic, bio-based and compostable bioplastic products. These products are used in premium packaging of high value consumables. E-Fund I